Mediscount | Best Online Pharmacy for Generic Drugs

Switglim MV 1mg/500mg/0.2mg Tablet

Manufactured By Akumentis Healthcare Ltd

Composition Glimepiride (1mg), Metformin (500mg), Voglibose (0.2mg)

Rs 128.61

MRP Rs 142.90

(10% OFF)

Includes all taxes

Package SIZE

( 10 tablets in 1 strip )

Out Of Stock

100% Authentic
Products

Free
Shipping*

Products
Return Policy

Information about Switglim MV 1mg/500mg/0.2mg Tablet

Uses / Indications:

Switglim MV 1mg/500mg/0.2mg Tablet is used in the treatment of type 2 diabetes.

Pregnancy interaction:

Switglim MV 1mg/500mg/0.2mg Tablet may be unsafe to use during pregnancy.Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.

Expert advice:

Not Available

Side Effects:

Hypoglycemia (low blood sugar level), Nausea, Diarrhoea, Altered taste, Flatulence, Stomach pain, Headache, Skin rash, Respiratory tract infection.

How to use:

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Switglim MV 1mg/500mg/0.2mg Tablet is to be taken with food.Switglim MV 1mg/500mg/0.2mg Tablet may cause stomach upset if taken on empty stomach.

How it works:

Switglim MV 1mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines: Glimepiride, metformin and voglibose. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas to lower the blood glucose. Metformin is a biguanide which lowers glucose production in the liver, delays glucose absorption from intestines and increases the body's sensitivity to insulin. Voglibose is an alpha-glucosidase inhibitor which prevents breakdown of complex sugars into simple sugars such as glucose. This prevents blood glucose from rising very high after meals.